PACS · PACS Group, Inc.

Summary

PACS Group, Inc. appointed Patrick H. Conway, MD, MSc to its Board of Directors as a Class III director effective March 4, 2026, upon recommendation of the Nominating and Corporate Governance Committee. Dr. Conway, CEO of Optum, brings extensive clinical, regulatory, and healthcare leadership experience to support the company's post-acute care strategy.

Key takeaways

• Board appointed Patrick H. Conway, MD, MSc as Class III director effective March 4, 2026
• Term expires at 2027 annual stockholder meeting
• Participates in non-employee director compensation program from November 25, 2025 proxy statement
• Enters standard indemnification agreement
• No arrangements, family relationships, or material interests disclosed
• Currently CEO of Optum with prior CMS Deputy Administrator role